Castration

Castration (also known as gonadectomy) is any action, surgical, chemical, or otherwise, by which a biological male loses use of the testicles. Surgical castration is bilateral orchiectomy (excision of both testes), and chemical castration uses pharmaceutical drugs to inactivate the testes. Castration causes sterilization (i.e., prevents them from reproducing); it also greatly reduces the production of certain hormones, such as testosterone. Surgical castration in animals is often called neutering.

The term "castration" is sometimes also used to refer to the removal of the ovaries in the female, otherwise known as an oophorectomy or, in animals, spaying. Estrogen levels drop precipitously following oophorectomy, and long-term effects of the reduction of sex hormones are significant throughout the body.

Castration of non-human animals is intended for favouring a desired development of the animal or of its habits, or preventing overpopulation.

History

Castration was frequently used for religious or social reasons in certain cultures in Europe, South Asia, Africa, and East Asia. After battles in some cases, winners castrated their captives or the corpses of the defeated to symbolize their victory and seize their "power". Castrated men — eunuchs – were often admitted to special social classes and were used particularly to staff bureaucracies and palace households: in particular, the harem. Castration also figured in a number of religious castration cults. Other religions, such as Judaism, were strongly opposed to the practice. The Leviticus Holiness code, for example, specifically excludes eunuchs or any males with defective genitals from the priesthood, just as castrated animals are excluded from sacrifice.

Podcasts:

PLAYLIST TIME:

Castrated

by: Severe Torture

Seeking and murdering
Devouring the meat
Misanthropic awakening
In the name of the father you'll suffer
You will crawl, mentally aborted
The time of your death is now coming
You will die, spiritually castrated
Eating your entrails out
As a hungry vulture
No one can hear you
Your voice is paralyzed
Cutting and beating
Causing mass carnage
You wish not to be who you are
You can beg but you will not survive
I can't wait for your brain cells to die
When I cut off this head I despise
I can see that you're not more than flesh
Now you're dying you won't resurrect
On your knees for a god I reject
Decomposing and locked in your grave




Latest News for: castrated

Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports ...

GetNews 06 Mar 2025
The latest healthcare forecast report provides an in-depth analysis of Castrate-resistant Prostate Cancer, offering comprehensive insights into the Castrate-resistant Prostate Cancer revenue trends, prevalence, and treatment landscape.

Castrate-Sensitive Prostate Cancer Treatment Market Size in the 7MM is expected to grow by 2034, ...

GetNews 05 Mar 2025
Castrate-Sensitive Prostate Cancer Companies ... Prostate cancer is the second most common cancer in men can be categorized into castrate-sensitive (castration-sensitive prostate cancer , and castration-resistant prostate cancer (mCRPC).

Institutional Level Crazy And Castrated - Looney Tunes

Bitchute 27 Feb 2025
Go to the source via the article link to view the video or click the video icon ....

Metastatic Castration-Resistant Prostate Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 20 Feb 2025
It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products ... Patients on the study must continue androgen deprivation therapy (ADT) unless surgically castrated.

Castrate resistant Prostate Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 19 Feb 2025
DelveInsight’s, “Castrate Resistant Prostate Cancer Pipeline Insight” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Castrate Resistant Prostate Cancer pipeline landscape.

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

PR Newswire 19 Feb 2025
Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC) ... alone in poor-risk, metastatic, castration-resistant prostate cancer in ENZA-p (ANZUP 1901).
  • 1
×